Upload
gregory-gardner
View
219
Download
6
Tags:
Embed Size (px)
Citation preview
APHEIS 2Air Pollution and Health: A European Information System
A Health Impact Assessment of Air PollutionIn 26 European Cities
Emilia Maria Niciu1, Anna Paldy2, Eszter Erdei2, Michal Krzyzanowski3 Sylvia Medina4, Antonio Placencia5, on behalf of the Apheis network
1- Institutul de Sanatate Publica (Institute of Public Health), Bucharest, Romania 2- Jozsef Fodor National Center for Public Health, National Institute of Environmental
Health), Budapest, Hungary3- WHO European Centre for Environment and Health, Bonn Office, Germany
4- Institut de Veille Sanitaire, Saint-Maurice, France 5- Institut Municipal de Salut Pública (Municipal Institute of Public Health), Barcelona, Spain
ISEE CEE Chapter ,Balaton, Hungary, 4-6 October 2003
Co-funded by:
* Pollution-Related Diseases Programme of Health and Consumer Protection DG of the European Commission, contract Nos.:
• SI2.131174 [99CVF2-604]
• SI2.297300 [2000CVG2-607]
• SI2.326507 [2001CVG2-602]
* Participating institutions in 12 European countries
Who funds Apheis
Network
* Network of environmental and public-health professionals
* 16 centres16 centres totalling 26 cities26 cities in 12 European countries12 European countries
* Each centre part of a city, regional or national institution active in the field of environmental health
What methods did we use
Network
What methods did we use
APHEIS cities (26)
Steering Committee (Boston, USA)
(Tel-Aviv, Israel)
What methods did we use
Exposure assessment
(local networks, European Env. Agency; WHO collaborating centre for air quality control, Berlin; European Reference Laboratory Air Pollution, Ispra)
Health outcomes monitoring(local/national institutes of public health, EUROSTAT,
WHO)
Quantitative relationships ofexposure and health-effect
estimates
(APHEIS)
Health impact assessment (cases, population, attributable risks)
(APHEIS, WHO-ECEH)
Dissemination of information for defined target audiences(APHEIS)
Decision makers
Citizens
Air quality management/Public-health actions
Evaluation (European Commission)
E&H professionals
Network
What methods did we use
APHEIS coordination centre
Paris and Barcelona
Advisory groupsExposure assessmentEpidemiologyStatisticsPublic health Health impact assessment
Participating APHEIS Cities
Technical committeeExposure assessmentEpidemiologyStatisticsPublic HealthHealth Impact Assessment
City committeeNEHAPsLocal/national authoritiesMedical/environmental sciencesCitizens
Local/regional coordinator
Network
Created five advisory groups: public health; health-impact assessment; epidemiology; exposure assessment; statistics
Drafted guidelines for designing and implementing the surveillance system, and for developing a standardised protocol for data collection and analysis for HIA
Review of capacities for HIA in institutions of participating cities
Actions, steps and resultsduring the first year
Implement or adapt organisational models designed during first year
Collect and analyse data for health-impact assessment
Prepare different health-impact scenarios
Prepare HIA report in standardised format (HIA in 26 cities)
Actions, steps and resultsduring the second year
1. Specify exposure
* PM10, BS
* Urban background stations
Five main steps in HIA
2. Define the appropriate health outcomes
* Acute effects* Acute effects
- Premature mortality excluding accidents and violent deaths
- Hospital admissions for respiratory diseases 65+ age group
- Hospital admissions for cardiac diseases all ages
* Chronic effects* Chronic effects
- Premature mortality
Five main steps in HIA
3. Specify the exposure-response functions
* Short-term exposure: APHEA2
Five main steps in HIA
PM10 Black smokeHealth
indicatorRR for
10 µg/m395%CI RR for
10 µg/m395%CI
TotalmortalityAll agesICD9 <800
1.006 1.004-1.008 1.006 1.003-1.008
Respiratoryhospitaladmissions65 years+ICD9 460-519
1.009 1.006-1.013 1. 001 1.000-1.009
Cardiachospitaladmissionsall agesICD9 410-414,427,428
1.005 1.002-1.008 1.011 1.004-1.018
3. Specify the exposure-response functions
* Long-term exposure: HIA in Austria, France and Switzerland based on two American cohort studies (Künzli et al, 2000).
Five main steps in HIA
Health indicator RR for 10 µg/m3 95%CI Total mortality
30 years + ICD9 <800
1.043 1.026-1.061
4. Derive population baseline frequency measures for health outcomes
5. Calculate number of attributable cases in target population
Five main steps in HIA
HIA modelKünzli, Kaiser, Medina et al, Lancet 2000; 356: 795 - 801
PM10
Incidence/prevalence
Attributable cases
Reference level PM10
Scenarios
E-R function
Observed level: annual mean
Demographic characteristicsDemographic characteristics
* Nearly 39 million39 million inhabitants in Western and Eastern Europe ( 34 mil.34 mil. in 2121 WEWE cities 5 mil5 mil. in 5 CEE5 CEE cities)
* Proportion of people over 65 years: 15%15%,, with highest proportion in Barcelona and lowest in London
Descriptive findingsDescriptive findings
Air pollution levelsAir pollution levels
* PMPM1010 - measurements provided by 19 cities:
Bordeaux, Bucharest, Budapest, Celje, Cracow, Gothenburg, Lille, Ljubljana, London, Lyon, Madrid, Marseille, Paris, Rome, Seville, Stockholm, Strasbourg, Tel Aviv and Toulouse
* Black SmokeBlack Smoke - measurements provided by 15 cities:
Athens, Barcelona, Bilbao, Bordeaux, Celje, Cracow, Dublin, Le Havre, Lille, Ljubljana, London, Marseille, Paris, Rouen and Valencia
Descriptive findings
Distribution of Distribution of annual mean levelsannual mean levels (10th and 90th percentiles) of (10th and 90th percentiles) of PM10PM10
Descriptive findingsDescriptive findings
0
10
20
30
40
50
60
70
80
90
100
Bordea
ux
Buchar
est *
Budapes
t
Celje
Craco
w
Gothen
burg
Lille
Ljublja
na
London
Lyon
Mad
rid
Mar
seill
e
Paris
Rome
Sevill
e
Stock
holm
Strasb
ourg
Tel A
viv
Toulouse
µg/m3
2005
2010
Distribution of Distribution of annual mean levelsannual mean levels (10th and 90th percentiles) of (10th and 90th percentiles) of Black SmokeBlack Smoke
Descriptive findingsDescriptive findings
0
20
40
60
80
100
120
Athen
s
Barce
lona
Bilbao
Bordea
ux
Celje
Craco
w
Dublin
Le Hav
re
Lille
Ljublja
na
London
Mar
seill
e
Paris
Rouen
Valen
cia
µg/m3
Health indicators :Health indicators : Standardised mortality rates for all causes of Standardised mortality rates for all causes of deaths in the 26 citiesdeaths in the 26 cities
Descriptive findingsDescriptive findings
0
200
400
600
800
1000
1200
Athen
s
Barce
lona
Bilbao
Bordea
ux
Buchar
est
Budapes
t
Celje
Craco
w
Dublin
Gothen
burg
Le Hav
re
Lille
Ljublja
na
London
Lyon
Mad
rid
Mar
seill
e
Paris
Rome
Rouen
Sevill
e
Stock
holm
Strasb
ourg
Tel A
viv
Toulouse
Valen
cia
Rate / 100 000 /year
Health indicatorsHealth indicators: : Incidence rates for Incidence rates for hospital admissionshospital admissions in 22 cities in 22 cities
( 8 with ( 8 with emergency admissionsemergency admissions, 14 with , 14 with general admissionsgeneral admissions))
Descriptive findingsDescriptive findings
0
500
1000
1500
2000
2500
3000
3500
4000
Barce
lona
Bilbao
Gothen
burg
London
Mad
rid
Sevill
e
Stock
holm
Valen
cia
Bordea
ux
Buchar
est
Celje
Le Hav
re
Lille
Ljublja
na
Lyon
Mar
seill
e
Paris
Rome
Rouen
Strasb
ourg
Tel A
viv
Toulouse
incidence rate of cardiac admissions all ages
incidence rate of respiratory admissions over 65years of age
Rate / 100 000 /year
Acute effects scenarios
* Reduction of PM10/BS levels to a 24-hour value of 50 24-hour value of 50 µg/mµg/m33 (2005 and 2010 limit values for PM10) on all days on all days exceeding this valueexceeding this value
* Reduction of PM10/BS levels to a 24-hour value of 20 24-hour value of 20 µg/mµg/m33 (to allow for cities with low levels of PM10/BS) on on all days exceeding this valueall days exceeding this value
* Reduction by 5 µg/mby 5 µg/m33 of all the 24-hour daily values of all the 24-hour daily values of PM10/BS (to allow for cities with low levels of PM10/BS)
Health impact assessment findingsHealth impact assessment findings
Chronic effects scenariosChronic effects scenarios
* Reduction of the annual mean valueannual mean value of PM10 to a level of 40 40 µg/mµg/m33 (2005 limit values for PM10)
of 20 µg/m20 µg/m33 (2010 limit values for PM10)
of 10 µg/m10 µg/m33 (to allow for cities with low levels of PM10)
* Reduction by 5 µg/mby 5 µg/m33 of the annual mean value of the annual mean value of PM10 (to allow for cities with low levels of PM10)
Health impact assessment findingsHealth impact assessment findings
Potential benefits of reducing daily PM10 levels by 5 µg/mPotential benefits of reducing daily PM10 levels by 5 µg/m33 - Number of deaths per 100 000 inhabitants attributable to the acute effects of PM10 (95% C.I.) - Number of deaths per 100 000 inhabitants attributable to the acute effects of PM10 (95% C.I.)
HIA findings: PM10 PM10 acute-effects scenarios
0
1
2
3
4
5
6
7
Bordea
ux
Buchar
est
Budapes
t
Celje
Craco
w
Gothen
burg
Lille
Ljublja
na
London
Lyon
Mad
rid
Mar
seill
e
Paris
Rome
Sevill
e
Stock
holm
Strasb
ourg
Tel A
viv
Toulouse
Rate/100 000/year
Potential benefits of reducing daily black smoke levels by 5 µg/mPotential benefits of reducing daily black smoke levels by 5 µg/m33- Number of deaths per 100 000 - Number of deaths per 100 000 inhabitants attributable to the acute effects of black smoke (95%C.I.) inhabitants attributable to the acute effects of black smoke (95%C.I.)
HIA findings: Black SmokeBlack Smoke acute-effects scenarios
0
1
2
3
4
5
6
Athen
s
Barce
lona
Bilbao
Bordea
ux
Celje
Craco
w
Dublin
Le Hav
re
Lille
Ljublja
na
London
Mar
seill
e
Paris
Rouen
Valen
cia
Rate /100 000 /year
Potential benefits of reducing annual mean values of PM10 by 5 µg/mPotential benefits of reducing annual mean values of PM10 by 5 µg/m33- Number of deaths per 100 000 inhabitants attributable to the - Number of deaths per 100 000 inhabitants attributable to the chronic effects of PM10 (95% C.I.)chronic effects of PM10 (95% C.I.)
HIA findings: PM10 PM10 chronic-effects scenarios
0
5
10
15
20
25
30
35
40
45
50
Bordea
ux
Buchar
est
Budapes
t
Celje
Craco
w
Gothen
burg
Lille
Ljublja
na
London
Lyon
Mad
rid
Mar
seill
e
Paris
Rome
Sevill
e
Stock
holm
Strasb
ourg
Tel A
viv
Toulouse
Rate /100 000 / year
CEE CITIESCEE CITIES
• out of a total of 32 mil in 19 cities out of a total of 32 mil in 19 cities
• HIA for long term exposure on total mortality found that HIA for long term exposure on total mortality found that
5 547 (3 368 - 7 744) premature death could be prevented annually if PM10 5 547 (3 368 - 7 744) premature death could be prevented annually if PM10 concentrations were reduced by 5 µg/mconcentrations were reduced by 5 µg/m33
HIA findings: PM10 in CEE citiesPM10 in CEE cities
CITY population 1999
mean annual
PM10 ug/m3 -1999
NUMBER OF DEATH - LONG TERM BENEFIT of reducing mean annual val. PM10 by 5 ug/m3
/100.000 NUMBER OF DEATH - SHORT TERM BENEFIT
of reducing daily val. PM10 by 5 ug/m3
/100.000
BUCHAREST 2,028,000 73 450.1 22.2 66.5 3.3BUDAPEST 1,775,587 29.5 559.6 31.5 82.7 4.7CELJE 50,121 36 12.9 25.8 1.9 3.8CRACOW 738,150 45.4 139.1 18.9 20.6 2.8LJUBLIANA 267,763 35.7 58.5 21.9 8.7 3.2TOTAL 4,859,621 43.92 1220.2 25.1 180.4 3.7
Standardised protocol for data collection and analysisStandardised protocol for data collection and analysis
Conservative approach :Conservative approach :
* Did not consider newborn or infant mortality separately
* Did not consider many other health outcomes listed by WHO
* Did not consider independent effect of ozone
* Used range of reference levels in different scenarios
Interpretation of findingsInterpretation of findings
Transferability of Exposure-Response (E-R) functions:Transferability of Exposure-Response (E-R) functions:
* Short-term exposure: Question avoided by using E-R functions developed by APHEA 2
* Long-term exposure: Open question - used U.S. E-R functions
Interpretation of findingsInterpretation of findings
ConclusionsConclusions* Our HIA provides a conservative but accurate and
detailed picture of the impact of air pollution on health in 26 European cities, and shows that air pollution continues to threaten public health in Europe.
* Even very small and achievable reductions in air pollution levels have an impact on public health
* This impact justifies taking preventive measures even in cities with low levels of air pollution
Interpretation of findings
Apheis 2002-2003
To keep our HIA as accurate and up-to-date as possible:
- Produce new exposure-response functions on short-term effects of AP
- Calculate years of life lost or reduction in life expectancy, in addition to the attributable number of deaths based on long-term effects
Actions, steps and resultsduring the third year (2002-03)
To fulfill our mission of making our learnings available to the broadest possible audiences, and to evaluate the usefulness of our work on HIA among those who need to know:
- Explore and understand how best to meet the information needs of policy makers concerned with the impact of air pollution on public health
and
- Understand how to meet those needs in terms of content and form
Actions, steps and resultsduring the third year
Apheis is a multiyear, multiphase proactive public-health programme
Each phase builds on learnings of previous phase
First broad-based European HIA of air pollution on both the city and European levels simultaneously
Consistent with other HIAs on air pollution worldwide
Translates epidemiological findings into decision-making tool
One more brick in the wall of evidence that air pollution continues to threaten public health
The broad view
The future
Epheis Environmental Pollution and Health: A European
Information System
Background Call for proposals DGSANCO 2003-2008
ENHIS Environment and Health Information System (WHO- ECEH Bonn)
Six modules:1. Identification of relevant policies/corresponding needs2. Development of Indicators3. Methods for data retrieval/processing 4. Creation of NCC, networking5. Integrate HIA (Epheis)6. Database development and maintenance
Coordination WHO-BonnSteering CommitteeLength first year :1 Feb 2004-30 Jan 2005
ObjectiveComparative risk assessment (CRA) of different environmental risk factors in Europe
o Selected environmental risk factors
o Method based on HIA and CRA
For further information please visit:
www.apheis.org
1. University of Athens, Athens, Greece 2. Institut Municipal de Salut Pública (Municipal Institute of Public Health),
Barcelona, Spain3. Departamento de Sanidad, Gobierno Vasco, Vitoria-Gasteiz, Spain4. Institutul de Sanatate Publica (Institute of Public Health), Bucharest, Romania 5. Jozsef Fodor National Center for Public Health, National Institute of
Environmental Health), Budapest, Hungary6. National Institute of Hygiene, Warsaw, Poland7. Saint James Hospital, Dublin, Ireland8. Institut de Veille Sanitaire, Saint-Maurice, France9. Inštitut za Varovanje Zdravja RS, (Institute of Public Health), Ljubljana,
Republic of Slovenia
Who are our partners
10. Saint George’s Hospital Medical School, London, UK
11. Dirección General de Salud Pública, Consejeria de Sanidad,
Comunidad de Madrid (Department of Public Health, Regional
Ministry of Health, Madrid Regional Government), Madrid, Spain
12. ASL RM/E Local Health Authority Roma E, Rome, Italy
13. Escuela Andaluza de Salud Pública (Andalusia School of Public
Health), Granada, Spain
14. Umeå University, Department of Public Health and Clinical
Medicine, Umeå, Sweden
15. Tel Aviv University, Tel Aviv, Israel
16. Escuela Valenciana de Estudios para la Salud (Valencia School
of Health Studies), Valencia, Spain
Who are our partners
Steering CommitteeSteering CommitteeRoss Anderson, Saint George’s Hospital Medical School, London, UKEmile De Saeger, Joint Research Centre, Institute for Environment and
Sustainability, Ispra, ItalyKlea Katsouyanni, Department of Hygiene and Epidemiology, University
of Athens, Athens, Greece Michal Krzyzanowski, WHO European Centre for Environment and Health,
Bonn Office, GermanyHans-Guido Mücke, Umweltbundesamt - Federal Environmental Agency,
WHO Collaborating Centre, Berlin, Germany Joel Schwartz, Harvard School of Public Health, Boston, USARoel Van Aalst, European Environmental Agency, Copenhagen, Denmark
Who are our partners
CoordinatorsCoordinators Sylvia Medina, Institut de Veille Sanitaire (Institute of Public
Health), Saint-Maurice, France Antoni Plasència, Institut Municipal de Salut Pública (Municipal
Institute of Public Health), Barcelona, Spain
Programme AssistantProgramme Assistant Claire Sourceau, Institut de Veille Sanitaire, Saint-Maurice, France
Who are our partners